Ortho Regenerative Technologies - ORTH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.35
  • Forecasted Upside:
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0 (0.00%)

This chart shows the closing price for ORTH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ortho Regenerative Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ORTH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ORTH

Analyst Price Target is $1.35
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Ortho Regenerative Technologies in the last 3 months. The average price target is $1.35, with a high forecast of $1.35 and a low forecast of $1.35. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for ORTH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Ortho Regenerative Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/13/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/11/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/9/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/8/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/7/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/11/2022Noble FinancialInitiated CoverageBuy$1.35
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/12/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/11/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/10/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/9/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/9/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/8/2023
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/7/2023

Current Sentiment

  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Ortho Regenerative Technologies logo
Ortho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,500 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ortho Regenerative Technologies?

The following sell-side analysts have issued reports on Ortho Regenerative Technologies in the last year: Noble Financial.
View the latest analyst ratings for ORTH.

What is the current price target for Ortho Regenerative Technologies?

1 Wall Street analysts have set twelve-month price targets for Ortho Regenerative Technologies in the last year. Their average twelve-month price target is $1.35. Noble Financial has the highest price target set, predicting ORTH will reach $1.35 in the next twelve months. Noble Financial has the lowest price target set, forecasting a price of $1.35 for Ortho Regenerative Technologies in the next year.
View the latest price targets for ORTH.

What is the current consensus analyst rating for Ortho Regenerative Technologies?

Ortho Regenerative Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ORTH will outperform the market and that investors should add to their positions of Ortho Regenerative Technologies.
View the latest ratings for ORTH.

What other companies compete with Ortho Regenerative Technologies?

How do I contact Ortho Regenerative Technologies' investor relations team?

Ortho Regenerative Technologies' physical mailing address is 16667 Hymus Blvd, KIRKLAND, QC H9H 4R9, Canada. The company's listed phone number is +1-514-7820951. The official website for Ortho Regenerative Technologies is www.orthorti.com. Learn More about contacing Ortho Regenerative Technologies investor relations.